Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease
暂无分享,去创建一个
H. Brenner | D. Rothenbacher | W. Koenig | H. Scharnagl | M. Nauck | W. Maerz | A. Imhof | A. Hoffmeister | N. Khuseyinova
[1] A. von Eckardstein,et al. Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. , 2001, Journal of the American College of Cardiology.
[2] J. Danesh,et al. Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.
[3] G. Lowe,et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. , 2000, Clinical chemistry.
[4] D. Wilcken,et al. Lp(a) and conventional risk profiles predict the severity of coronary stenosis in high-risk hospital-based patients. , 2000, Australian and New Zealand journal of medicine.
[5] N. Yoshida,et al. Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. , 2000, Journal of the American College of Cardiology.
[6] E. Angles-cano,et al. Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: An in vitro study using plasma from children with idiopathic nephrotic syndrome. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[7] G. Dangas,et al. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. , 1998, Journal of the American College of Cardiology.
[8] D. Lane,et al. Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. , 1998, European heart journal.
[9] P. Ridker,et al. Lipoprotein (a), Lipids, Aspirin, and Risk of Myocardial Infarction in the Physician's Health Study , 1998, Journal of cardiovascular risk.
[10] J. Kaski,et al. Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris. , 1998, Journal of the American College of Cardiology.
[11] G. Dagenais,et al. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. , 1998, Journal of the American College of Cardiology.
[12] P. Harpel,et al. Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells. , 1997, Circulation.
[13] K. Bailey,et al. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. , 1997, Circulation.
[14] R. Rosenson,et al. Lipoprotein Lp(a) excess and coronary heart disease. , 1997, Archives of internal medicine.
[15] D. Nagel,et al. Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. , 1997, Atherosclerosis.
[16] S. Fortmann,et al. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[17] M. Ikäheimo,et al. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. , 1996, Atherosclerosis.
[18] A. Dobson,et al. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a) in men and women. , 1996, Journal of the American College of Cardiology.
[19] P. Wilson,et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. , 1996, JAMA.
[20] D. Sgoutas,et al. Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells. , 1996, Atherosclerosis.
[21] C. Nienaber,et al. Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosis , 1995, Coronary artery disease.
[22] G. Breithardt,et al. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[23] P. Wilson,et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. , 1994, Circulation.
[24] R. Muche,et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) , 1994, European journal of clinical investigation.
[25] D. Wilcken,et al. Determinants of severity of coronary artery disease in Australian men and women. , 1994, Circulation.
[26] J. Ordovás,et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. , 1994, JAMA.
[27] J. Salonen,et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. , 1994, Atherosclerosis.
[28] N. Wald,et al. Apolipoproteins and ischaemic heart disease: implications for screening , 1994, The Lancet.
[29] R. Lawn,et al. The relationship of lipoprotein (a) to hemostasis , 1993 .
[30] P. Ridker,et al. A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.
[31] G. De Backer,et al. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. , 1992, Clinical chemistry.
[32] G. Thorgeirsson,et al. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. , 1992, The American journal of cardiology.
[33] M. Pike,et al. A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. , 1992, Atherosclerosis.
[34] U. Beisiegel. Lipoprotein (a) in the arterial wall , 1991, European heart journal.
[35] J. Huttunen,et al. Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. , 1991, Atherosclerosis.
[36] K. Hajjar,et al. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. , 1991, The Journal of biological chemistry.
[37] L. Wilhelmsen,et al. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.
[38] G. Roubin,et al. Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease. , 1990, The American journal of cardiology.
[39] E. Plow,et al. Lp(a): An Interloper into the Fibrinolytic System? , 1990, Thrombosis and Haemostasis.
[40] J. Loscalzo,et al. Lipoprotein(a), fibrin binding, and plasminogen activation. , 1990, Arteriosclerosis.
[41] W. Parmley. Prevalence and Clinical Significance of Silent Myocardial Ischemia , 1989, Circulation.
[42] M. Seishima,et al. Transient changes of serum lipoprotein(a) as an acute phase protein. , 1989, Atherosclerosis.
[43] J. Breslow,et al. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.
[44] A. Scanu,et al. A potential basis for the thrombotic risks associated with lipoprotein(a) , 1989, Nature.
[45] N. Morton,et al. Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.
[46] S. Humphries,et al. Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men. , 2001, The American journal of medicine.
[47] K. Hajjar,et al. The role of lipoprotein(a) in atherogenesis and thrombosis. , 1996, Annual review of medicine.
[48] A. Gotto,et al. CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .